DISEASE-MODIFYING ANTI-April 19th, 2021
FiledApril 19th, 2021Document Type: Guideline Version: 3.3 Date of Issue: March 2019 Review Date: March 2022 Lead Director: Medical Director Post Responsible for Update: Consultant Rheumatologist Ratifying Committee: APG Ratified by them in the minutes of: March 2021 Distribution to: All Trust staff via the Trust Intranet